2001-August Archives by Subject
Starting: Fri Aug 3 13:48:03 2001
Ending: Fri Aug 31 18:41:09 2001
Messages: 102
- [Pharm-policy] (no subject)
Kermit Johnson
- [Pharm-policy] (no subject)
B Garcia
- [Pharm-policy] (no subject)
Joel Lexchin
- [Pharm-policy] [Fwd: Pfizer donates Diflucan to 50 countries]
Ron Macinnis
- [Pharm-policy] ACTION ALERT: Call Senators & demand $2 billion for the Global
AIDS Fund
Paul Davis
- [Pharm-policy] affordcd4.com
James Love
- [Pharm-policy] Amir, IIPI and Boston Globe on patents in Africa
James Love
- [Pharm-policy] Amir, IIPI and Boston Globe on patents in Africa
James Love
- [Pharm-policy] Andrew Pollack on Genentech royalty dispute
James Love
- [Pharm-policy] Another report on Brazil
James Love
- [Pharm-policy] Another US bill on parallel imports
James Love
- [Pharm-policy] Babelfish on Tribune de Geneve article
James Love
- [Pharm-policy] Babelfish translation of LeMonde article on German Velasquez
James Love
- [Pharm-policy] Bill Haddad on Polish data exclusivity
James Love
- [Pharm-policy] Boston Globe on NIH royalties for drug R&D
Mike Palmedo
- [Pharm-policy] Brazil and Roche resume talks
Mike Palmedo
- [Pharm-policy] Brazil annouces compulsory license for nelfinavir
Mike Palmedo
- [Pharm-policy] Brazil Ministry of Health's August 22 announcement of compulsory
licensing of Nelfinavir patent
James Love
- [Pharm-policy] Brazil Roche
James Love
- [Pharm-policy] Brazil story on Viracept
James Love
- [Pharm-policy] Brazil's threat to break Roche patent on nelfinavir
Paul Davis
- [Pharm-policy] Brook Baker: THE IMPORTANCE OF COMBO-DRUGS: ANOTHER ARGUMENT FOR
COMPULSORY AND VOLUNTARY LICENCES
James Love
- [Pharm-policy] China to seek price reductions from AIDS drug makers
James Love
- [Pharm-policy] CIPR website information
Rob Fitter
- [Pharm-policy] Comment on Reporting in Brazil compulsory licensing case
James Love
- [Pharm-policy] Company offers to copyright =?iso-8859-1?Q?people=92s?= DNA against
unwanted cloning
James Love
- [Pharm-policy] Econ Times: Zydus to cut prices of AIDS drugs
Mike Palmedo
- [Pharm-policy] Ernst&Young's Report
George M. Carter
- [Pharm-policy] Excise and customs tax lifted on AIDS drugs in India
Mike Palmedo
- [Pharm-policy] for People who have problems posting to the list
James Love
- [Pharm-policy] FT Editorial on Roche/Brazil dispute
James Love
- [Pharm-policy] FTAA Comments from Essential Action
Robert Weissman
- [Pharm-policy] Further dirty tricks in Australia: the battle continues
Ken Harvey
- [Pharm-policy] FW: NATAF: Scholarships Deadline August 31st
Gonsalves, Gregg
- [Pharm-policy] FW: Press statment: Dominican Republic, US trade pressure, and
Paul Davis
- [Pharm-policy] Geron/U of Wisconsin suit over stem cell patents
love@cptech.org
- [Pharm-policy] Good Book on How Generic Entry Affects Pricing
Charisse Basilio
- [Pharm-policy] humor (relevant)
A.J. Peticolas
- [Pharm-policy] Information on equivalence groups
B Garcia
- [Pharm-policy] Lancet: AIDS treatment is possible anywhere in the world.
Paul Davis
- [Pharm-policy] Le Monde on threats against German Velasquez
Manon Ress
- [Pharm-policy] Letter in Support of Thai Government
Robert Weissman
- [Pharm-policy] Licensing Under Trips May Affect Pharma R&D in India
George M. Carter
- [Pharm-policy] Melody Peterson on Brazil/Roche compulsory license
James Love
- [Pharm-policy] Mickey Davis translation of Le Monde on threats against German Velasquez
James Love
- [Pharm-policy] Mickey Davis translation of Le Monde on threats against German Velasquez
Prof. Michael H. Davis
- [Pharm-policy] Multinationals are in control of the Therapeutic Goods Administration
Nelson Para Subramaniam
- [Pharm-policy] New Compulsory License in U.S.
Mike Palmedo
- [Pharm-policy] New policy at major medical journals
katie@CritPath.Org
- [Pharm-policy] NIH report on technology transfer and royalties
Mike Palmedo
- [Pharm-policy] NYT op-ed: Patents Could Block the Way to a Cure
Mike Palmedo
- [Pharm-policy] NYTimes editorial: Stinginess on AIDS
Paul Davis
- [Pharm-policy] On Wisconsin patent on stem cells
James Love
- [Pharm-policy] Online Pharmacies - Indiameds
James Love
- [Pharm-policy] Patent humour
Kate Raworth
- [Pharm-policy] Patent on both hand hair cutting method
James Love
- [Pharm-policy] pharm policy research needs
Paul Waraich
- [Pharm-policy] PhRMA on PC R&D Report
James Love
- [Pharm-policy] Polish dispute over data exclusivity
love@cptech.org
- [Pharm-policy] Price competition in Dominican Republic
James Love
- [Pharm-policy] Project Inform Treatment Action Network Alert
Paul Davis
- [Pharm-policy] Protecting Indigenous Rights
George M. Carter
- [Pharm-policy] Ranbaxy 'victory' in US Courts for GSK generic drug!!
Dwijen Rangnekar
- [Pharm-policy] Ranbaxy Press Release (July)- generic 3TC gets Brazilian approval
Mike Palmedo
- [Pharm-policy] Re: [Ip-health] Amir, IIPI and Boston Globe on
patents in Africa
James Love
- [Pharm-policy] Re: [Ip-health] Amir, IIPI and Boston Globe on patents in Africa
amir_attaran@harvard.edu
- [Pharm-policy] Re: [Ip-health] Boston Globe on NIH royalties for drug R&D
Prof. Michael H. Davis
- [Pharm-policy] Re: [Ip-health] Company offers to copyright =?iso-8859-1?Q?people=92s?=
DNA againstunwanted cloning
Prof. Michael H. Davis
- [Pharm-policy] Re: [Ip-health] Patent on both hand hair cutting method
calestous_juma@harvard.edu
- [Pharm-policy] Re: [Ip-health] Patent on both hand hair cutting method
Laurie Racine
- [Pharm-policy] Re: [Ip-health] Patent on both hand hair cutting method
calestous_juma@harvard.edu
- [Pharm-policy] Re: [Ip-health] Scope of IP protections and Girl from Ipanema
Prof. Michael H. Davis
- [Pharm-policy] Re: [Ip-health] Sheryl Gay Stolberg in NYT on Patents and Stem Cell
Research
Prof. Michael H. Davis
- [Pharm-policy] Re: [Ip-health] Uganda Compulsory licensing case
Prof. Michael H. Davis
- [Pharm-policy] Re: Amir, IIPI and Boston Globe on patents in Africa
Udo Schuklenk
- [Pharm-policy] Re: CIPR website information
Rob Fitter
- [Pharm-policy] Re: Pharm-policy digest, Vol 1 #472 - 1 msg
Alacran7@aol.com
- [Pharm-policy] Re: Pharm-policy digest, Vol 1 #472 - 1 msg
Susan Finston
- [Pharm-policy] Re: Pharm-policy digest, Vol 1 #491 - 3 msgs
janet c collins
- [Pharm-policy] Reuters: Cipla launches 3-in-1 AIDS pill
Mike Palmedo
- [Pharm-policy] Reuters: Roche says Brazil near accord on AIDS
drug price
Shadlen, Kenneth
- [Pharm-policy] Reuters: Roche says Brazil near accord on AIDS drug price
Mike Palmedo
- [Pharm-policy] Roche claims Brazil needs notice to USG before enforcing Brazil law
James Love
- [Pharm-policy] Scope of IP protections and Girl from Ipanema
love@cptech.org
- [Pharm-policy] SF Chronicle: Scientists' 'publish or perish' credo now 'patent and
profit'
Mike Palmedo
- [Pharm-policy] Sheryl Gay Stolberg in NYT on Patents and Stem Cell Research
love@cptech.org
- [Pharm-policy] TAC/Oxfam/MSF on Reporting on Brazil case
James Love
- [Pharm-policy] TAG Basic Science Project Director job description
Alacran7@aol.com
- [Pharm-policy] test message -- please ignore
A.J. Peticolas
- [Pharm-policy] THE IMPORTANCE OF COMBO-DRUGS: ANOTHER ARGUMENT FOR COMPULSORY AND
VOLUNTARY LICENCES
James Love
- [Pharm-policy] Tim Weiner in NYT on Mexican pharmaceutical parallel imports
love@cptech.org
- [Pharm-policy] Timeline of Paclitaxel disputes
James Love
- [Pharm-policy] Tribune de Geneve on WHO's reaction to threats against Velasquez
Manon Ress
- [Pharm-policy] TRIPS Article 30
James Love
- [Pharm-policy] TRIPS Article 30 exceptions to patent rights
James Love
- [Pharm-policy] Uganda Compulsory licensing case
James Love
- [Pharm-policy] UNDUE INFLUENCE: Article from The American Prospect
Gonsalves, Gregg
- [Pharm-policy] uniform patient assistance application
Pat Zerega
- [Pharm-policy] US FTC pursues compulsory license for Unocal anti-smog patents
James Love
- [Pharm-policy] WP: AMA on pharma's gifts to doctors
Mike Palmedo
- [Pharm-policy] WSJ on marketing practices in India
love@cptech.org
- [Pharm-policy] WSJ: Merck-Medco lawsuit
Mike Palmedo
Last message date:
Fri Aug 31 18:41:09 2001
Archived on: Fri Aug 31 17:41:09 2001
This archive was generated by
Pipermail 0.05 (Mailman edition).